Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekFierceBiotech ↗
Zoll Medical, the maker of devices and software focused on cardiopulmonary and respiratory conditions, was sla…
The WeekBriefing
PwC says pharma and life sciences deals topped $65B in Q1 2026, led by big-ticket buys from Sun Pharma and GSK…
The WeekSTAT News ↗
Keep those letters coming!…
The WeekSTAT News ↗
When STAT polled our readers on 'health care' vs. 'healthcare,' about 60% of our readers voted for one word.…
The WeekAJMC ↗
Defunding Co-Payment Assistance Disrupted nAMD Care…
The WeekFiercePharma ↗
Before Aurobindo can complete its acquisition of Pennsylvania generics specialist Lannet, it will have to dive…
The WeekFierceBiotech ↗
As Moderna reshapes itself in the wake of the pandemic, the company on Thursday passed a key milestone in its …
The WeekBriefing
The company will steer R&D toward other pipeline priorities after updated results for its approved combo fell …
The WeekSTAT News ↗
Disability researchers across the country worry about their jobs, and the future of their institutions, as a d…
The WeekAJMC ↗
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to "Myeloma Maniacs"…
The WeekBioPharma Dive ↗
The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FD…
The WeekBioPharma Dive ↗
The biotech is advancing an anti-inflammatory drug that originated with vTv for inflammatory bowel diseases, l…
The WeekBioPharma Dive ↗
The companies didn't specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provid…
The WeekFiercePharma ↗
Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treat…
The WeekFierceBiotech ↗
F2G and Shionogi have released phase 3 data for the oral antifungal drug olorofim, demonstrating its non-infer…
The WeekBriefing
Regulators appear receptive to Moderna's flu vaccine, UniQure prepares a Huntington's filing, and Lilly announ…
The WeekSTAT News ↗
A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do…
The WeekDrug Channels ↗
Today's guest post comes from Nareda Mills, President of Patient Solutions at Inizio Engage. Nareda examines h…
The WeekDrug Channels ↗
Today's guest post comes from Nareda Mills, President of Patient Solutions at Inizio Engage. Nareda examines h…
The WeekDrug Channels ↗
Today's guest post comes from Nareda Mills, President of Patient Solutions at Inizio Engage. Nareda examines h…
The WeekPharmaVoice ↗
Vedana Therapeutics recently emerged from stealth with $46 million to support its mission of developing "anti-…
The WeekBioPharma Dive ↗
Including the heart drug developer's offering, four biotechs in 2026 have raised at least $400 million in IPO …
The WeekAJMC ↗
Study Finds Flaw in Method for Key Oncology Value-Based Care Model…
The WeekFiercePharma ↗
With pharma and life sciences deal values surpassing $65 billion in the first quarter, marking the strongest q…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.